Non-invasive portography: A microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis

British Journal of Radiology

Volumn 85, Issue 1013, 2012, Pages 587-595

  Maruyama, Hitoshi ^a   Okugawa, H ^a   Kobayashi, S ^a   Yoshizumi, H ^a   Takahashi, M ^a   Ishibashi, H ^a   Yokosuka, O ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUBUTANE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC PORTAL HYPERTENSION; INTERMETHOD COMPARISON; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MICROBUBBLE; NON INVASIVE PROCEDURE; PERCUTANEOUS TRANSHEPATIC PORTOGRAPHY; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; PORTAL VEIN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION, PORTAL; IMAGING, THREE-DIMENSIONAL; LIVER CIRRHOSIS; MALE; MICROBUBBLES; MIDDLE AGED; PORTAL PRESSURE; PORTAL VEIN; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84857053667     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25522379     Document Type: Article

References (33)

1. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-84. (Pubitemid 37523784)
2. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-8. (Pubitemid 28041564)
3. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003;38:S54-68.
4. Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med J 2005;35:45-9. (Pubitemid 40254767)
5. Hillaire S, Valla DC, Lebrec D. Non cirrhotic portal hypertension. Clin Liver Dis 1997;1:1223-40.
6. Benhamou JP, Valla DC. Intrahepatic portal hypertension. In: Bircher J, Benhamou JP, McIntyre N, et al, ed. Oxford textbook of clinical hepatology. 2nd edn. Oxford, UK: Oxford University Press; 1999. pp. 661-70.
7. Okuda K, Obata H. Idiopathic portal hypertension (hepatoportal sclerosis). In: Okuda K, Benhamou JP, eds. Portal hypertension. Clinical and physiological aspects. Tokyo, Japan: Springer; 1992. pp. 271-87.
8. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002;17:526-34. (Pubitemid 34748172)
9. Hillaire S, Bonte E, Denninger M-H, Casadevall N, Cadranel JF, Lebrec D, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275-80. (Pubitemid 34791461)
10. Ohnishi K, Saito M, Sato S, Terabayashi H, Iida S, Nomura F, et al. Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology 1987;92:751-8. (Pubitemid 17023741)
11. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17:6-16. (Pubitemid 34304381)
12. Okuda K, Kono K, Ohnishi K, Kimura K, Omata M, Koen H, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 1984;86:600-10. (Pubitemid 14164710)
13. Futagawa S, Fukazawa M, Horisawa M, Musha H, Ito T, Sugiura M, et al. Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR Am J Roentgenol 1980;134:917-23. (Pubitemid 10101799)
14. Nelson TR, Pretorius DH. Three-dimensional ultrasound imaging. Ultrasound Med Biol 1998;24:1243-70. (Pubitemid 29003648)
15. Downey DB, Fenster A, Williams JC. Clinical utility of three-dimensional US. Radiographics 2000;20:559-71.
16. Goldberg BB. Ultrasound contrast agents. London, UK: Mastin Dunitz; 1997.
17. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71. (Pubitemid 30033608)
18. Mitchell DG. Color Doppler imaging: principles, limitations, and artifacts. Radiology 1990;177:1-10. (Pubitemid 20317312)
19. Foley WD, Erickson SJ. Color Doppler flow imaging. AJR Am J Roentgenol 1991;156:3-13.
20. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler sonography. Radiology 1994;190:853-6.
21. Maruyama H, Matsutani S, Saisho H, Mine Y, Yuki H, Miyata K. Extra-low acoustic power harmonic images of the liver with Perflutren: novel imaging for real-time observation of liver perfusion. J Ultrasound Med 2003;22:931-8. (Pubitemid 37082560)
22. The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. 2nd edn. Tokyo, Japan: The Japan Society for Portal Hypertension; 2004. pp. 91-2.
23. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 2008;190:691-5. (Pubitemid 351304513)
24. Maruyama H, Takahashi M, Ishibashi H, Okugawa H, Okabe S, Yoshikawa M, et al. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 2009;29:708-14.
25. Futagawa S, Fukazawa M, Musha H, Isomatsu T, Koyama K, Ito T, et al. Hepatic venography in noncirrhotic idiopathic portal hypertension. Radiology 1981;141:303-9.
26. Ohto M, Kato H, Tsujii H, Maruyama H, Matsutani S, Yamagata H, et al. Vascular flow patterns of hepatic tumors in contrast-enhanced 3-dimensional fusion ultrasonography using plane shift and opacity control modes. J Ultrasound Med 2005;24:49-57. (Pubitemid 40039781)
27. Luo W, Numata K, Morimoto M, Kondo M, Takebayashi S, Okada M, et al. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology 2009;251:287-95.
28. Luo W, Numata K, Morimoto M, Nozaki A, Nagano Y, Sugimori K, et al. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods. AJR Am J Roentgenol 2009;192:165-73.
29. Marelli C. Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection. Eur Radiol 1999;9:S343-6.
30. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007;42:643-51. (Pubitemid 47262933)
31. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000;35:80-5. (Pubitemid 30033610)
32. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast enhanced US: comparison with histologic differentiation. Radiology 2007;244:898-906. (Pubitemid 47292103)
33. Maruyama H, Ishibashi H, Takahashi M, Imazeki F, Yokosuka O. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. Radiology 2009;252:587-94.